Ignite Creation Date:
2025-12-25 @ 2:45 AM
Ignite Modification Date:
2025-12-31 @ 1:46 AM
Study NCT ID:
NCT04945733
Status:
TERMINATED
Last Update Posted:
2024-09-19
First Post:
2021-06-23
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Amivantamab in Participants With Previously Treated Advanced or Metastatic Gastric or Esophageal Cancer
Sponsor:
Janssen Pharmaceutical K.K.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-08-30
Start Date Type:
ACTUAL
Primary Completion Date:
2023-07-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-07-03
Completion Date Type:
ACTUAL
First Submit Date:
2021-06-23
First Submit QC Date:
None
Study First Post Date:
2021-06-30
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-07-03
Results First Submit QC Date:
None
Results First Post Date:
2024-09-19
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-08-22
Last Update Post Date:
2024-09-19
Last Update Post Date Type:
ACTUAL